| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74ad3dd5949e18c908bea80d853e24d7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f3fa7858f21d1d9df6bd0b7ee6e876 |
| publicationDate |
2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018165720-A1 |
| titleOfInvention |
Agents for treating or preventing viral infections and uses therefor |
| abstract |
Disclosed are agents and methods for treatment or prevention of Flavivirus infections. In particular, the present invention discloses CD14 antagonist antibodies for use in treating or preventing disease associated with Flavivirus infections, including Dengue Virus infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021142445-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3612566-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116444673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116444673-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11692026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021158960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021243396-A1 |
| priorityDate |
2017-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |